Annual report [Section 13 and 15(d), not S-K Item 405]

Net Loss Per Share

v3.26.1
Net Loss Per Share
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Net Loss Per Share

13. Net Loss Per Share

The following table presents the calculation of basic and diluted net loss per share applicable to common stockholders. Basic net loss per share is calculated by dividing net loss attributable to common shareholders by the weighted-average number of shares outstanding during the period which includes 42,538,910 pre-funded warrants and shares held in abeyance from date of issuance.

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

Numerator:

 

 

 

 

 

 

Net loss

 

$

(48,259,189

)

 

$

(27,519,886

)

Denominator:

 

 

 

 

 

 

Weighted-average number of shares outstanding – basic and diluted

 

 

98,310,190

 

 

 

23,712,220

 

Net loss per share applicable to common stockholders – basic and diluted

 

$

(0.49

)

 

$

(1.16

)

 

The Company’s potentially dilutive securities have been excluded from the computation of diluted net loss per share applicable to common stockholders, prior to the application of the treasury stock method, because their effect would have been antidilutive for the periods presented. Therefore, the weighted average number of shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The potentially dilutive securities that have been excluded from the computation of diluted net loss per share include stock options and warrants to purchase common stock, restricted common stock and shares of common stock issued as contingent consideration in connection with the acquisition of CorHepta, for which the vesting conditions have not been met. The Company excluded the following potential shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated:

 

 

 

Year ended December 31,

 

 

 

2025

 

 

2024

 

Options to purchase shares of stock

 

 

38,204,120

 

 

 

16,904,050

 

Warrants to purchase shares of stock

 

 

162,048,400

 

 

 

26,134,671

 

Contingently issuable shares (see Note 7):

 

 

 

 

 

 

Restricted common stock

 

 

1,660,222

 

 

 

 

Contingent consideration

 

 

2,489,030

 

 

 

 

Total

 

 

204,401,772

 

 

 

43,038,721